165 related articles for article (PubMed ID: 31730015)
21. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
[TBL] [Abstract][Full Text] [Related]
22. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?
Xu P; Zeng M; Liu K; Shan Y; Xu C; Lin J
J Gastroenterol Hepatol; 2014 Feb; 29(2):330-6. PubMed ID: 24033853
[TBL] [Abstract][Full Text] [Related]
23. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
24. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
[TBL] [Abstract][Full Text] [Related]
26. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
28. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
29. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
30. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.
Iguchi T; Shirabe K; Aishima S; Wang H; Fujita N; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Oda Y; Maehara Y
Transplantation; 2015 Jun; 99(6):1236-42. PubMed ID: 25427164
[TBL] [Abstract][Full Text] [Related]
31. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
33. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
34. Different prognostic factors and strategies for early and late recurrence after adult living donor liver transplantation for hepatocellular carcinoma.
Hong SK; Lee KW; Yoon KC; Kim HS; Ahn SW; Kim H; Lee JM; Cho JH; Yi NJ; Suh KS
Clin Transplant; 2019 Oct; 33(10):e13703. PubMed ID: 31464006
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence?
Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; Iida T; Uemoto S
World J Surg; 2011 Jun; 35(6):1355-9. PubMed ID: 21424873
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
[TBL] [Abstract][Full Text] [Related]
37. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
[TBL] [Abstract][Full Text] [Related]
38. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
39. Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: A comparison of mean and minimum apparent diffusion coefficient values.
Zhao J; Li X; Zhang K; Yin X; Meng X; Han L; Zhang X
Medicine (Baltimore); 2017 Aug; 96(33):e7754. PubMed ID: 28816952
[TBL] [Abstract][Full Text] [Related]
40. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
